Voloridge Investment Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,828
Closed -$234K 1400
2024
Q2
$234K Sell
27,828
-34,558
-55% -$368K ﹤0.01% 1166
2024
Q1
$901K Sell
62,386
-190,917
-75% -$3.16M ﹤0.01% 981
2023
Q4
$5.45M Sell
253,303
-124,717
-33% -$2.23M 0.02% 599
2023
Q3
$7.27M Buy
378,020
+22,757
+6% +$485K 0.04% 544
2023
Q2
$9.03M Buy
355,263
+119,952
+51% +$3.46M 0.04% 486
2023
Q1
$8.51M Buy
235,311
+22,434
+11% +$788K 0.04% 496
2022
Q4
$8.43M Buy
212,877
+32,845
+18% +$1.37M 0.05% 481
2022
Q3
$8.39M Sell
180,032
-121,093
-40% -$5.62M 0.05% 498
2022
Q2
$13.2M Buy
301,125
+75,580
+34% +$4.16M 0.07% 365
2022
Q1
$16.3M Buy
225,545
+36,947
+20% +$2.66M 0.09% 292
2021
Q4
$15.3M Buy
+188,598
New +$18.9M 0.08% 340
2021
Q2
Sell
-14,173
Closed -$1.98M 1827
2021
Q1
$1.98M Buy
14,173
+5,105
+56% +$833K 0.01% 828
2020
Q4
$1.57M Buy
+9,068
New +$1.47M 0.01% 820
2019
Q4
Sell
-24,532
Closed -$2.11M 1396
2019
Q3
$2.11M Buy
+24,532
New +$1.86M 0.04% 439
2017
Q1
Sell
-15,414
Closed -$1.12M 724
2016
Q4
$1.12M Sell
15,414
-90,884
-85% -$7.78M 0.02% 483
2016
Q3
$11.1M Buy
106,298
+35,482
+50% +$3.2M 0.24% 71
2016
Q2
$5.22M Buy
+70,816
New +$4.81M 0.15% 136

Other funds holding NVRO

Voloridge Investment Management's NVRO Position: Q3 2024 in Review

Voloridge Investment Management sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 27,828 shares — an estimated $234K sold.

Voloridge Investment Management first reported a position in NVRO in Q2 2016 and held it in 17 quarters. The position peaked at $16.3M in Q1 2022. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Voloridge Investment Management reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 27,828 NEVRO CORP. shares in Q3 2024, an estimated $234K.
  • Voloridge Investment Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 17 quarters.
  • Voloridge Investment Management's NEVRO CORP. position peaked at $16.3M in Q1 2022.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Voloridge Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.